Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Frontiers in Neurology|October 26, 2019
Premorbid Alterations of Spontaneous Brain Activity in Elderly Patients With Early Post-operative Cognitive Dysfunction: A Pilot Resting-State Functional MRI StudyXixue Zhang, Hui Li, Yating Lv, et al.
European Journal of Neurology|October 10, 2025
Abnormal Enhanced Gamma Synchronization in the Default Mode Network Associated With Chronic PainZhaoshun Jiang, Fei Tao, Feidong Lv, et al.
BMC Anesthesiology|August 7, 2023
Effects of 30% vs. 60% inspired oxygen fraction during mechanical ventilation on postoperative atelectasis: a randomised controlled trialZhaoshun Jiang, Songbin Liu, Lan Wang, et al.
BMC Medicine|January 12, 2012
Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cellsYong Zhao, Zhaoshun Jiang, Tingbao Zhao, et al.
BMC Medicine|July 11, 2013
Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I/II clinical trialYong Zhao, Zhaoshun Jiang, Tingbao Zhao, et al.
Autoimmunity Reviews|February 2, 2022
Stem Cell Educator therapy in type 1 diabetes: From the bench to clinical trialsYong Zhao, Colette M Knight, Zhaoshun Jiang, et al.
Stem Cells Translational Medicine|July 8, 2017
Platelet-Derived Mitochondria Display Embryonic Stem Cell Markers and Improve Pancreatic Islet β-cell Function in HumansYong Zhao, Zhaoshun Jiang, Elias Delgado, et al.
Zhonghua Nei Ke Za Zhi|January 14, 2016
[Efficacy and safety of alogliptin in treatment of type 2 diabetes mellitus: a multicenter, randomized, double-blind, placebo-controlled phase III clinical trial in mainland China]Changyu Pan, Wenhui Li, Jiaoe Zeng, et al.
Nature Medicine|May 13, 2022
Dorzagliatin in drug-naïve patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trialDalong Zhu, Xiaoying Li, Jianhua Ma, et al.
Nature Medicine|May 13, 2022
Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trialWenying Yang, Dalong Zhu, Shenglian Gan, et al.
Pageof 3